Role of Protein Post-Translational Modifications in Cancer: Mechanisms and Therapeutic Opportunities
A special issue of Kinases and Phosphatases (ISSN 2813-3757).
Deadline for manuscript submissions: 30 May 2025 | Viewed by 12
Special Issue Editors
Interests: protein phosphorylation; acidic protein kinases; tyrosine kinases; kinase inhibitors, signal transduction; post-translational modifications; cancer; cystic fibrosis
Special Issues, Collections and Topics in MDPI journals
Interests: the dysregulation of signal transduction; metabolic pathway in cancer progression; drug resistance
Interests: cancer; cancer-stem-like cells; oxidative stress; circadian clock
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Post-translational modifications (PTMs) represent a major biochemical mechanism for increasing the diversity of the proteome, allowing proteins to undergo functional changes that can be dynamically adjusted in response to both intracellular and extracellular signals. In cancer, PTMs such as phosphorylation, ubiquitination, acetylation, glycosylation, and methylation are not merely secondary modifications; rather, they influence virtually every hallmark of cancer. These and other modifications regulate key cellular functions such as cell cycle progression, apoptosis, DNA repair, immune responses, and metabolism. However, cancer cells frequently hijack PTMs, exploiting these mechanisms to promote uncontrolled growth, evade apoptosis, drive metastasis, and resist treatment.
The targeting of these aberrant PTM pathways presents a vast array of potential avenues for therapeutic intervention. One of the most well-known examples is the aberrant tyrosine kinase activity of the BCR-ABL fusion protein in chronic myeloid leukemia. Imatinib, a pioneering therapeutic agent that targets this hyperactive kinase and was specifically developed for this purpose, exemplifies how correcting PTM-driven dysregulation can result in effective cancer treatment, opening the door to a wide range of cancer treatments.
This Special Issue will collect the latest research on the pivotal roles of PTMs in the diverse stages and forms of cancer, with particular interest in mechanistic studies aimed at revealing how specific PTMs contribute to tumor initiation, progression, and metastasis. Furthermore, comprehensive reviews of current treatments targeting PTMs, which should examine the efficacy of existing therapies and highlight new therapeutic avenues, will be welcomed.
By collecting a broad spectrum of research, the aim is to provide a deeper understanding of the molecular mechanism controlled by PTMs in tumors and of how manipulating PTMs can revolutionize cancer treatment and improve patient outcomes.
Dr. Mauro Salvi
Prof. Dr. Wei-Chien Huang
Dr. Josefa León
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Kinases and Phosphatases is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- phosphorylation
- acetylation
- methylation
- sumoylation
- ubiquitination
- glycosylation
- acylation
- signal transduction
- inhibitors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
